المؤلفون: Oliveira, AC, Vidal, JMR, Coll, CF, Do Nascimento, J, Rodriguez, M, Domingo-Domenech, E, Mercadal, S, Encuentra, M, Gallardo, D, Ribera, JMR, Sarra, J, Sureda, A, Barca, EG

المصدر: LEUKEMIA & LYMPHOMA
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::986837333cab5fd2cd590e30f9574382
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3418

المؤلفون: Varela, SB, Abrisqueta, P, Gonzalez, BS, Gine, E, Romero, S, Alcoceba, M, Barca, EG, de Villambrosia, SG, Sancho, JM, Gomez, P, Castellvi, J, Lopez, A, Bosch, F

المصدر: Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::59feb11695a03f9e9c40f4552506ca7d
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6654

المؤلفون: Duell J; Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Germany., Abrisqueta P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain., Andre M; Department of Hematology, CHU UCL Namur, Yvoir, Belgium., Augustin M; Department of Hematology and Oncology, Klinikum Nuernberg, Paracelsus Medical University, Nuernberg, Germany., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Barca EG; Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Jurczak W; Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland., Kalakonda N; Department of Molecular and Clinical Cancer University of Liverpool, Liverpool, UK., Liberati AM; Università degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy., Maddocks KJ; Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Menne T; Freeman Hospital, The Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK., Nagy Z; Semmelweis University, Budapest, Hungary., Tournilhac O; CHU de Clermont-Ferrand, Clermont Ferrand, France., Bakuli A; MorphoSys AG, Planegg, Germany., Amin A; MorphoSys AG, Planegg, Germany., Gurbanov K; MorphoSys AG, Planegg, Germany., Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

المصدر: Hematological oncology [Hematol Oncol] 2023 Jun; Vol. 41 Suppl 2, pp. 437-439.

نوع المنشور: Congress; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*/therapy, Humans ; Switzerland ; Congresses as Topic

المؤلفون: Del Mar Onteniente Gomis M; Hospital Universitario 12 de Octubre, Dermatology Department, Madrid, Spain., Matilla BN; Hospital Universitario Puerta de Hierro, Hematology Department, Madrid, Spain., Pujol Vallverdú RM; Hospital del Mar, Dermatology Department, Barcelona, Spain., Escudero AC; Hospital Universitario Clínic i Provincial, Dermatology Department, Barcelona, Spain., Paz IZ; Hospital Universitario Puerta de Hierro, Oncology Radiation Department, Madrid, Spain., Barca EG; Institut Catalá D'Oncología - Hospitalet, Hematology Department, Barcelona, Spain., Montserrat CM; Hospital Universitario de Bellvitge, Dermatology Department, Barcelona, Spain., Andújar MM; Hospital Universitario Virgen del Rocío, Dermatology Department, Sevilla, Spain., Ferriols AP; Hospital General Universitario de Valencia, Dermatology Department, Valencia, Spain., Curto CR; Hospital General Universitario de Salamanca, Dermatology Department, Salamanca, Spain., de Misa Cabrera RF; Hospital Universitario Nuestra Señora de Candelaria, Dermatology Department, Santa Cruz de Tenerife (Islas Canarias), Spain., Gil MH; Hospital Universitario Puerta de Hierro, Dermatology Department, Madrid, Spain., Niebla AM; Hospital Universitario Vall d'Hebron/VHIO, Hematology Department, Barcelona, Spain., Rios Rull PJ; Hospital Universitario Nuestra Señora de Candelaria, Hematology Department, Santa Cruz de Tenerife (Islas Canarias), Spain., De la Cruz Vicente F; Hospital Universitario Virgen del Rocío, Hematology Department, Sevilla, Spain., Izu Belloso RM; Hospital de Basurto, Bilbao (Vizcaya), Spain., García-Sancho AM; Hospital General Universitario de Salamanca, Hematology Department, Salamanca, Spain., Parera Amer ME; Hospital Son Llàtzer, Dermatology Department, Palma de Mallorca (Islas Baleares), Spain., Mascuñano RC; Hospital Universitario Fundación Jiménez Díaz, Hematology Department, Madrid, Spain., Ramón Quiles MD; Hospital Clínico Universitario, Dermatology Department, Valencia, Spain., Carreres AS; Hospital Clínico Universitario, Hematology Department, Valencia, Spain., Del Campo García R; Hospital Son Llàtzer, Hematology Department, Palma de Mallorca (Islas Baleares), Spain., Machan S; Hospital Universitario Fundación Jiménez Díaz, Dermatology Department, Madrid, Spain., Ester PV; Kyowa Kirin Farmacéutica, S.L., Medical Department, Madrid, Spain., Garnelo JB; Kyowa Kirin Farmacéutica, S.L., Medical Department, Madrid, Spain., López BS; E-C-BIO, S.L. Medical Department, Madrid, Spain., Ortiz Romero PL; Hospital Universitario 12 de Octubre, Dermatology Department, Madrid, Spain.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Oct; Vol. 156 Suppl 1, pp. S29-S30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Younes A; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, Cornell University, New York, NY, USA younesa@mskcc.org wskimsmc@skku.edu., Salles G; Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon, France., Martinelli G; European Institute of Oncology, Milan, Italy., Bociek RG; University of Nebraska Medical Center, Omaha, NE, USA., Barrigon DC; Hospital Universitario de Salamanca, Spain., Barca EG; Hospital Duran i Reynals-ICO, Barcelona, Spain., Turgut M; Ondokuz Mayis University, Samsun, Turkey., Gerecitano J; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, Cornell University, New York, NY, USA., Kong O; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Pisal CB; Novartis Healthcare Pvt. Ltd., Hyderabad, India., Tavorath R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Kim WS; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea younesa@mskcc.org wskimsmc@skku.edu.

المصدر: Haematologica [Haematologica] 2017 Dec; Vol. 102 (12), pp. 2104-2112. Date of Electronic Publication: 2017 Sep 29.

نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Phosphoinositide-3 Kinase Inhibitors*, Aminopyridines/*pharmacology , Lymphoma, Non-Hodgkin/*drug therapy , Morpholines/*pharmacology, Adult ; Aged ; Aged, 80 and over ; Aminopyridines/adverse effects ; Aminopyridines/therapeutic use ; Female ; Humans ; Lymphoma, Follicular/complications ; Lymphoma, Follicular/drug therapy ; Lymphoma, Large B-Cell, Diffuse/complications ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Mantle-Cell/complications ; Lymphoma, Mantle-Cell/drug therapy ; Lymphoma, Non-Hodgkin/complications ; Male ; Middle Aged ; Morpholines/adverse effects ; Morpholines/therapeutic use ; Recurrence ; Remission Induction ; Salvage Therapy/methods

المؤلفون: Lucas A; Department of Radiation Oncology, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain., Barca EG; Department of Hematology, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain., Servitje O; Department of Dermatology, Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain., Abenoza L; Department of Hematology, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain., González MN; Department of Radiation Oncology, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain., Macià M; Department of Radiation Oncology, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain., Lozano A; Department of Radiation Oncology, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain.

المصدر: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [Rep Pract Oncol Radiother] 2010 Jul 06; Vol. 15 (4), pp. 107-9. Date of Electronic Publication: 2010 Jul 06 (Print Publication: 2010).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Via Medica Country of Publication: Poland NLM ID: 100885761 Publication Model: eCollection Cited Medium: Print ISSN: 1507-1367 (Print) Linking ISSN: 15071367 NLM ISO Abbreviation: Rep Pract Oncol Radiother Subsets: PubMed not MEDLINE

المؤلفون: Garcia-Marco JA; Hospital Universitario Puerta de Hierro, Madrid, Spain. jagarciam@aehh.org, Panizo C, Garcia ES, Deben G, Alvarez-Larran A, Barca EG, Sancho JM, Penarrubia MJ, Garcia-Cerecedo T, Garcia Vela JA

المصدر: Cancer [Cancer] 2009 May 01; Vol. 115 (9), pp. 1892-8.

نوع المنشور: Evaluation Study; Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Liposomes*, Cytarabine/*therapeutic use , Lymphoma/*drug therapy , Lymphoma/*pathology , Meningeal Carcinomatosis/*drug therapy , Meningeal Carcinomatosis/*secondary, Adult ; Aged ; Cytarabine/administration & dosage ; Cytarabine/adverse effects ; Drug Evaluation ; Female ; Humans ; Injections, Spinal ; Male ; Middle Aged ; Quality of Life ; Retrospective Studies